Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.
Also called NCT04479722
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 210 participants
- Registry
-
NCT04479722
-
- Other papers using this trial's data
- Left atrial appendage closure with the AnchorMan or Watchman devices: 12-month results of the SAFE-PROTECT randomised trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04479722. Randomized; no masking; primary purpose prevention. Start 2021-03-03 (actual); primary completion 2022-09-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke
- Acronym
- SAFE-PROTECT
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Intervention (Device)
- Left atrial appendage closure procedure
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
Record details
- Record id
cardio:ct-nct04479722- Content hash
0f74c69ebb4f9ada718cd87ebaa77c84861feac416dfac80090512301ae6dc4c